Positive effects of GLP‐1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db / db mice with degenerative diabetes-Reference-Cited by-同舟云学术

Positive effects of GLP‐1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db / db mice with degenerative diabetes

Published:2014-11-18 Issue:3 Volume:31 Page:248-255
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Moffett Rachel Charlotte¹,Patterson Steven¹²,Irwin Nigel¹,Flatt Peter R.¹

Affiliation:

1. SAAD Centre for Pharmacy and DiabetesUniversity of Ulster Coleraine Northern Ireland UK

2. School of Life and Health SciencesGlasgow Caledonian University Glasgow UK

Funder

European Foundation for the Study of Diabetes

Department of Education and Learning, Northern Ireland

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.2608

Reference28 articles.

1. Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls

2. Enteroendocrine hormone mimetics for the treatment of obesity and diabetes

3. In Vitro Proliferation of Adult Human Beta-Cells

4. Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue

5. Clinical efficacy of GLP‐1 agonists and their place in the diabetes treatment algorithm;Unger J;J Am Osteopath Assoc,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity;European Journal of Clinical Pharmacology;2024-02-17

2. GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy;Expert Opinion on Pharmacotherapy;2023-03-24

3. Efficacy of IAPP suppression in mouse and human islets by GLP-1 analogue conjugated antisense oligonucleotide;Frontiers in Molecular Biosciences;2023-02-06

4. Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations;Journal of Endocrinological Investigation;2021-06-30

5. Proglucagon-Derived Peptides as Therapeutics;Frontiers in Endocrinology;2021-05-18